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Background: A decoction of Crassocephallum vitellinum (Benth.) S. Moore (Asteraceae) is used in Kagera Region to
treat peptic ulcers. This study seeks to evaluate an aqueous ethanol extract of aerial parts of the plant for safety and
efficacy.
Methods: An 80% ethanolic extract of C. vitellinum at doses of 100, 200, 400 and 800 mg/kg body wt was
evaluated for ability to protect Sprague Dawley rats from acidified ethanol gastric ulceration in comparison with
40 mg/kg body wt pantoprazole. The extract and its dichloromethane, ethyl acetate, and aqueous fractions were
also evaluated for acute toxicity in mice, brine shrimp toxicity, and antibacterial activity against four Gram negative
bacteria; Escherichia coli (ATCC 25922), Salmonella typhi (NCTC 8385), Vibrio cholera (clinical isolate), and
Streptococcus faecalis (clinical isolate). The groups of phytochemicals present in the extract were also determined.
Results: The ethanolic extract of C. vitellinum dose-dependently protected rat gastric mucosa against ethanol/HCl insult to
a maximum of 88.3% at 800 mg/kg body wt, affording the same level of protection as by 40 mg/kg body wt pantoprazole.
The extract also exhibited weak antibacterial activity against S. typhi and E. coli, while its ethyl acetate, dichloromethane and
aqueous fractions showed weak activity against K. pneumonia, S.typhi, E. coli and V. cholera. The extract was non-toxic to
mice up to 5000 mg/kg body wt, and the total extract (LC50 = 37.49 μg/ml) and the aqueous (LC50 = 87.92 μg/ml), ethyl
acetate (LC50 = 119.45 μg/ml) and dichloromethane fractions (88.79 μg/ml) showed low toxicity against brine shrimps.
Phytochemical screening showed that the extract contains tannins, saponins, flavonoids, and terpenoids.
Conclusion: The results support the claims by traditional healers that a decoction of C.vitellinum has antiulcer activity. The
mechanism of cytoprotection is yet to be determined but the phenolic compounds present in the extract may contribute
to its protective actions. However, the dose conferring gastro-protection in the rat is too big to be translated to clinical
application; thus bioassay guided fractionation to identify active compound/s or fractions is needed, and use of more
peptic ulcer models to determine the mechanism for the protective action.
Keywords: Crassocephalum vitellinum, Traditional medicine, Gastric cytoprotection, Antimicrobial, Acute, Toxicity* Correspondence: mmoshi@muhas.ac.tz
1Department of Biological and Preclinical Studies, Muhimbili University of
Health and Allied Sciences, P.O. Box 65001, Dar es Salaam, Tanzania
Full list of author information is available at the end of the article
© 2014 Moshi et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly credited.
Moshi et al. BMC Research Notes 2014, 7:91 Page 2 of 7
http://www.biomedcentral.com/1756-0500/7/91Background
The Kagera region has a culture rich in traditional medi-
cine practice, but the majority of plants used in this region
are poorly documented and have not yet been evaluated
for safety and efficacy. Crassocephallum vitellinum
(Benth.) S. Moore (ASTERACEAE); Synonym: Gynura
vitellina Benth is among plants used in Bukoba for the
treatment of peptic ulcer disease [1]. The aerial parts of C.
vitellinum are boiled with water and the resulting decoc-
tion is taken regularly for management of peptic ulcers
[1]. Reports from other areas show that in Kenya the plant
is used for the treatment of stomach complications, mal-
aria and mouth infections in children [2], while in Zaire
the leaves are burnt with those of the cultivated yam and
the ash is applied to scarifications for the treatment of
swollen legs [3]. In Southern Rwanda C.vitellinum is used
as a hepatoprotective remedy which has eventually been
linked to its antioxidant properties [4,5]. An extract of the
plant protected rats against acetaminophen induced liver
toxicity, and in addition it reversed barbiturate induced
sleep in guinea pigs [4]. The leaves are used for the treat-
ment of female sterility, strong fever, dysmenorrhea, con-
stipation, childhood diseases and facilitate the deliverance
of placenta [4]. The filtrate of crushed leaves and flowers
of the plant combined with those of Plantago palmata
Hoof.f., Vernonia auriculifera Hiern and Physalis peruvi-
ana L. is used for treatment of whooping cough [6], while
the leaves are used for management of anorexia [7] and
for antenatal care [8]. The leaves are used in veterinary
medicine for treatment of mastitis, fever, and to facilitate
lactation and activity has been linked to the flavonoid con-
tent of the leaves [9]. The antioxidant and antibacterial ac-
tivity of the essential oils of the aerial parts of the plant
was recently reported [10]. In refugee camps in Tanzania,
traditional healers use the leaves of C. vitellinum for con-
stipation and abortion [11].The leaves are also used by the
Haya people to treat gonorrhea [1].
This study was done to evaluate the efficacy of an ex-
tract of the aerial parts for protection against acidified
ethanol induced gastric ulceration in Spague Dawley rats.
The extract was also tested for antibacterial activity.
Phytochemical screening was done to determine the
groups of compounds present in the extract, while acute
toxicity in mice and brine shrimp lethality test were done
to determine safety of the extract.
Methods
Materials
Tryptone Soya broth was purchased from HIMEDIA®
(Himedia Laboratories Pvt Ltd, Mumbai, INDIA; p-Iodoni-
trotetrazolium chloride (INT) from SIGMA® (Sigma-
Aldrich®, St Louis, USA); pantoprazole (lyophilized powder
for i.v injection; Batch No. JKJ 3534D and manufactured by
Sun Pharmaceutical Industries Ltd, Halol-Baroda Highway,Halol-389350, Gujarat, India.), was sourced from a local
pharmacy. Ethanol (absolute) was purchased from Fluka
Chemie GmbH (Sigma-Aldrich®, Zwijndrecht, Netherlands),
while dimethyl sulfoxide (DMSO) was purchased from
Sigma® (Poole, Dorset, UK). Cyclophosphamide, NEOPHOS
500® (CIPLA Ltd, MIDC Boisar, INDIA) was purchased
from a local Pharmacy in Dar es Salaam, Tanzania. Escheri-
chia coli (ATCC 25922), Salmonella typhi (NCTC 8385),
Vibrio cholerae (clinical isolate), and Klebsiella pneumoniae
(clinical isolate) were obtained from the Department of
Microbiology and Immunology, Muhimbili University of
Health and Allied Sciences (MUHAS). The brine shrimp
eggs were bought from Aquaculture Innovations (Grahams-
town 6140, South Africa) and sea salt was prepared locally
by evaporating water collected from the Indian Ocean, along
the Dar es Salaam Coast.
Collection of plant material
The aerial parts of Crassocephallum vitellinum (Benth.)
S. Moore (ASTERACEAE) were collected by an expe-
rienced botanist, Mr. Haji O. Selemani of the Department
of Botany, University of Dar es Salaam and voucher
specimen no. MH 164569 is kept at the Herbarium of
the Institute of Traditional Medicines, Muhimbili University
of Health and Allied Sciences.
Preparation of plant extracts
The air-dried plant material was ground into powder using
a plant milling machine. The plant material was macerated
in 80% ethanol at room temperature for 24 h and filtered
through Whatman No.1 filter paper. This procedure was
repeated 3 times to ensure complete extraction of plant
material. The pooled extract was concentrated by evapo-
ration under reduced pressure in a rotary evaporator at
40 ºC. The extract yield was 31 g from 292 g of dry plant
material (10.62%).
Testing for antiulcer activity
Both male and female Sprague Dawley rats weighing
100-188 g were used. The rats were fasted for 36 h but
allowed free access to drinking water. Thirty rats were
randomly allocated to 5 groups of 6 rats each. The rats
in group one (Solvent control) were pre-dosed orally
with 5 ml/kg body wt of 1% tween 80 in normal saline;
rats in group two were pre-dosed orally with 40 mg/kg
body wt pantoprazole (Positive control), and rats in
groups 3, 4 and 5 were pre-dosed orally with 200, 400
and 800 mg/kg body wt solution of C. vitellinum extract
one hour before oral administration of 5 ml/kg body wt
of the ulcerogenic mixture. The ulcerogenic mixture
contained 80% ethanol, 5% hydrochloric acid and 15%
distilled water. The animals were euthanized by ether
anaesthesia 4 h after administration of acidified ethanol.
The stomachs were removed, cut open along the greater
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the severity of ulcers. The degree of ulceration (Ulcer
index) was graded according to a method previously de-
scribed by Shay and colleagues [12] as follows: 0 = no le-
sions (normal stomach); 0.5 = hyperemia (red coloration);
1 = hemorrhagic spots, 2 = 1–5 small ulcers; 3 =many
small ulcers, 4 =many small and large ulcers; 6 = stomach
full of ulcers along with perforations. Percentage protec-
tion was calculated by comparison with the untreated
control group Percentage protection [12]
¼ 100 − Mean ulcer index of treated group
Mean ulcer index of control group
 100
Statistical analysis
The results are expressed as mean ± standard deviation
(SD). The results of mean ulcer index were compared
using the non-parametric Kruskal-Wallis test.
Testing for antibacterial activity
Test organisms
Four Gram-negative bacteria (enterobactericeae) namely
Escherichia coli, Salmonella typhi, Vibro cholera, and
Klebsiella pneumonea were used, which were obtained
from the Department of Microbiology and Immunology,
Muhimbili University of Health and Allied Sciences.
Determination of minimum inhibitory concentrations (MICs)
Minimum inhibitory concentrations (MICs) were deter-
mined using the microdilution method [13]. A stock solu-
tion of the extract was prepared by dissolving 100 mg of
the 80% ethanol extract into 1 ml of DMSO (100 mg/ml).
Each of the 96 well microtitre plates were first preloaded
with 100 μl of tryptic soya broth followed by addition of
100 μl of the extract into the first wells of the rows to
make a total volume of 200 μl in the first wells. After thor-
ough mixing 100 μl were transferred from the first row
wells into the next row wells. The process was repeated
sequentially to the last well at the bottom where 100 μl
was discarded. Thereafter, 100 μl of the bacterial suspen-
sion (0.5Mac Farland standard turbidity) was then added
to each well to make a final volume of 200 μl in each well.
Gentamicin sulphate (100 μg/ml) was used as a standard
drug. Rows containing broth, DMSO and bacteria were in-
cluded as negative controls (solvent control) and rows
containing broth and bacteria only were included in order
to see whether there was bacterial growth or not (growth
control). The plates were then incubated at 37°C for 24 h.
After incubation for 24 h, at 37°C, 40 μl of 0.02% p-
iodonitrotetrazolium (INT) chloride solution was added
to each well followed by incubation for 1 h at 37°C. Bac-
terial growth was indicated by a change in color to pink in
the wells. Absence of bacterial growth was indicated by nocolor change of the dye. The first concentration at which
no bacterial growth occurred was taken as the MIC.Brine shrimps lethality test
The brine shrimp lethality test (BST) was used to predict
the presence, in the extract, of cytotoxic activity [14]. Solu-
tions of the extract were made in DMSO at concentrations
ranging from 8–240 μg/ml and incubated in duplicate vials
with brine shrimp larvae. Ten brine shrimp larvae were
placed in each of the duplicate vials. Control brine shrimp
larvae were placed in a mixture of artificial sea water
(3.8 g/l sea salt) and DMSO only. After 24 h the nauplii
were examined against a lighted background, and the aver-
age number of live larvae in each duplicate vial was deter-
mined. The mean percentage mortality was plotted against
the logarithm of concentrations and the concentration kill-
ing fifty percent of the larvae (LC50) was determined from
the graph [15].Data analysis
The mean results of brine shrimp mortality against the
logarithms of concentrations were plotted using the Fig P
computer program (Biosoft Inc, USA), which also gives
the regression equations. The regression equations were
used to calculate LC16, LC50 and LC84 values. Confidence
intervals (95% CI) were then calculated using the three re-
sults [14,15]. An LC50 value greater than 100 μg/ml was
considered to represent an inactive compound or extract.Acute toxicity test
Acute toxicity was done according to OECD guidelines
425 [16]. Both male and female Theiller’s original albino
mice were used. The mice were acclimatized in an air
conditioned room at 20°C for 7 days before experimen-
tation. Before dosing with extracts the mice were starved
for 18–24 h with access to adequate drinking water, in
cages with wire mesh bottoms to prevent coprophagy.
Initially a dose of 1000 mg/kg body wt was administered
to a group of 6 mice (3 male and 3 female), and mice
observed for signs of immediate toxicity and/or death
for 72 h. If no toxicity was observed another group of 3
male and 3 female mice was given a dose of 2000 mg/kg
body wt and the same observations made. If no signs of
toxicity or death occurred doses were sequentially in-
creased to 3000, 4000, and 5000 mg/kg body wt, respect-
ively. Extracts were solubilized in 1% tween 80 in normal
saline and administered at a single dose volume of 5 ml/kg
body wt or two doses of 5 ml/kg body wt depending on
solubility, within a one hour interval. A control group was
administered a single 5 ml or 5 ml/kg body wt of 1%
tween 80 twice to match with the dose of administered
plant extract.
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The 80% ethanol extract was tested for the presence of ste-
roids, saponins, flavonoids, terpenoids, cardiac glycosides,
alkaloids and tannins using standard methods [17,18].
Ethical clearance
This study was given ethical clearance by the Muhimbili




The 80% ethanol extract of C. vitellinum showed a dose-
dependent protection against ethanol/HCl induced gastric
ulceration. Table 1 shows that the extract protected the rat
stomach from ulceration by 55% at a dose of 200 mg/kg
body wt (P ≤ 0.001) and this increased to 71.7(P ≤ 0.001),
and 88.3%(P ≤ 0.001) at 400 and 800 mg/kg body wt as
compared to solvent treated rats, respectively. This was the
same percentage protection as 40 mg/kg body wt of the
proton pump inhibitor, pantoprazole. Figure 1 shows that
at 800 mg/kg body wt the stomach appeared similar to that
of the rats pretreated with 40 mg/kg body wt pantoprazole.
Figure 2 shows the dose–response relationship for control,
400 and 800 mg/kg body wt of the plant extract
Antibacterial activity
The results for antibacterial activity (Table 2) indicate that
the total extract had weak activity against Salmonella typhi
and Escherichia coli with MIC of 3.125 mg/ml. When the
extract was fractionated to aqueous, ethyl acetate and di-
chloromethane fractions the results show that the ethyl
acetate fraction was active against the four bacteria used;
i.e. K. pneumoniae, S. typhi, E. Coli and V. cholera, and was
active against more bacteria than the total extract. Both the
dichloromethane and ethyl acetate extracts had very weak
activity against all the four bacteria used.
Brine shrimp lethality test
The brine shrimp test results (Table 3) show that generally
the total extract (LC50 = 37.49 μg/ml) and the aqueous, di-
chloromethane and ethyl acetate fractions all exhibited
moderately low brine shrimp toxicity.Table 1 Antiulcer activity of an 80% ethanol extract of aerial





5. 40 mg/kg body wt pantoprazole
Each value is a mean of results of 6 rats. * = significant P ≤ 0.001 compared to solveAcute toxicity in mice
The total extract up to 5000 mg/kg body wt did not show
any signs of toxicity to mice and all the mice survived to
the 28 days of observation period.
Phytochemical Screening
The results of phytochemical screening show that the 80%
ethanol extract of Crassocephalum vitellinum contains
tannins, saponins, flavonoids and triterpenes.
Discussion
The mechanism of ethanol gastric ulceration is due to dir-
ect toxic effect on the epithelium leading to necrotic le-
sions, depletion of gastric mucus which breaks the mucosal
barrier, increase permeability of gastric mucosa leading to
increased leakage of hydrogen ions from the lumen, back
diffusion of acid, and decrease transluminal electrical po-
tential difference [19-21]. Ethanol also causes changes in
mucosal blood flow, destroy microvascular and non-
vascular cells, mast cell degranulation, neutophil mediated
mucosal injury, and depletion of certain oxygen free radical
scavengers [22]. In addition to depletion of free radical
scavengers, free radicals are released from the metabolism
of ethanol [22], and this if further exacerbated by inhibition
of the biosynthesis of cytoprotective prostaglandins [23].
In this study pantoprazole showed a clear protective ac-
tion against acidified ethanol ulceration, probably suggest-
ing the role of gastric acid in the acidified ethanol-induced
gastric ulceration. Appearance of the pantoprazole treated
rat gastric mucosa shows a big difference in gross appear-
ance as compared to the solvent controls. On the other
hand the aqueous ethanol extract of C. vitellinum, at
800 mg/kg body wt, conferred the same level of protection
to the rat gastric mucosa (88.3%) as 40 mg/kg body wt
pantoprazole. An important question here is what is the
basis for the protective action of the extract. Certainly
there is no adequate evidence to allow us to suggest the
mechanism of gastro-protection. The results of phyto-
chemical screening showed that the extract of the aerial
parts of C. vitellinum contains tannins, flavonoids and ter-
penoids which are phenolic compounds. Plant phenolic
compounds are known to be antioxidants and free radical
scavengers [24]. Owing to the established fact that
ethanol-induced gastric ulceration is associated withparts of C. vitellinum
Mean ulcer index (n = 6) % age protection
6 0
2.7 ± 1.0 55.0*
1.7 ± 1.4 71.7*
0.7 ± 0.4 88.3*




Figure 1 Photograph showing the stomach following insult with ethanol/HCl (80%/5%) mixture. In (A) the rat was pre-dosed with the solvent
before insult with ethanol/HCl mixture. In (B) the rat was pre-dosed with 800 mg/kg body wt of 80% ethanol extract of C. vitellinum before exposure





Figure 2 Photographs of rat gastric mucosa showing the dose-dependent effect of C. vitellinum against acidified ethanol ulceration of rat
gastric mucosa. A = Solvent control; B = 400 mg/kg body wt plant extract; C= 800 mg/kg body wt plant extract; D = 40 mg/kg body wt pantoprazole.
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Table 2 Antibacterial activity of ethyl acetate, DCM and aqeous fractions of C.vitellinum ethanol extract
Gram-ve
test isolates
MICs (mg/ml) of 80% ethanol extract and its fractions
80% ethanol extract (total) Ethyl acetate (fraction) DCM (fraction) Aqeous (fraction)
K.pneumonea - 6.25 12.5 12.5
S.typhii 3.125 3.125 12.5 12.5
E.coli 3.125 3.125 6.25 6.25
V.cholera - 3.125 12.5 12.5
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oxygen free radicals, proteases and lysosomal enzymes
[22], there is a strong indication that the C. vitellinum ex-
tract owes its anti-ulcerogenic effect partly due to the
presence of flavonoids, tannins and terpenoids which have
antioxidant and free radical scavenging activity. The anti-
oxidant properties of this plant have been reported in an-
other study [4].
The 80% ethanol extract and its fractions exhibited some
antibacterial activity against four Gram negative bacteria,
which seems to be highest in the ethyl acetate fractions. It
was intended to test the extracts for inhibitory effect
against Helicobacter pylori which is implicated in peptic
ulcer disease. However, it was not possible to get these or-
ganisms from any commercial source or through other la-
boratories. It was decided to test the extracts against the
four enterobacteria to just get indicative results, but it does
not mean in any way that getting positive results is a direct
indication that the extracts would also automatically be ac-
tive against H. pylori but does suggest that the extracts
may be useful for treating other intestinal conditions re-
lated to infection by these bacteria. This notion is sup-
ported by some of the traditional medicine uses [5,8,9].
The extract of C. vitellinum showed no significant
changes in animal behavior or adverse signs of toxicity
during post treatment evaluation of the mice following
treatment with up to 5000 mg/kg body wt, thus suggesting
that it is safe when administered acutely. Similar findings
were observed in brine shrimp toxicity test in which both
the total extract and its fractions showed minimal toxicity.
Conclusion
These results support the claim by traditional healers that
the extract of the aerial parts of C.vitellinum has antiulcer
activity. Since the dose conferring maximum protection isTable 3 The effect C. vitellinum total extract and its
fractions on brine shrimp toxicity
Extracts LC50 (μg/ml) 95% CI(μg/ml)
80% ethanol extract 37.49 27.98 - 50.16
Aqueous fraction 87.92 63.71-121.33
Ethyl acetate fraction 119.45 86.56-164.84
Dichloromethane fraction 88.79 69.37-113.65very big it is unlikely that the results can have immediate
clinical application. While it may be suggested that phen-
olic compounds contribute to the protective actions of the
extract, there is need to do bioassay guided fractionation
to identify active compound/s or fractions. The mechan-
ism for the protective action also remains to be a subject
for further studies.
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